Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies

Medical Oncology, 06/12/2012

The data show that elderly with a good performance status and few co–morbidity may be treated as younger patients; moreover, age confirms a negative impact on survival while Charlson Index Co–morbidity (CCI)≤2 did not correlated with overall survival (OS).

Print Article Summary Cat 2 CME Report